ID   MDR1_HUMAN              Reviewed;        1280 AA.
AC   P08183; A8K294; B5AK60; Q12755; Q14812;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 3.
DT   10-MAY-2017, entry version 203.
DE   RecName: Full=Multidrug resistance protein 1;
DE            EC=3.6.3.44;
DE   AltName: Full=ATP-binding cassette sub-family B member 1;
DE   AltName: Full=P-glycoprotein 1;
DE   AltName: CD_antigen=CD243;
GN   Name=ABCB1; Synonyms=MDR1, PGY1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS VAL-185 AND ALA-893,
RP   AND POLYMORPHISM.
RX   PubMed=2876781; DOI=10.1016/0092-8674(86)90595-7;
RA   Chen C.-J., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M.,
RA   Roninson I.B.;
RT   "Internal duplication and homology with bacterial transport proteins
RT   in the mdr1 (P-glycoprotein) gene from multidrug-resistant human
RT   cells.";
RL   Cell 47:381-389(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-893.
RX   PubMed=1967175;
RA   Chen C.-J., Clark D.P., Ueda K., Pastan I., Gottesman M.M.,
RA   Roninson I.B.;
RT   "Genomic organization of the human multidrug resistance (MDR1) gene
RT   and origin of P-glycoproteins.";
RL   J. Biol. Chem. 265:506-514(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS VAL-185 AND ALA-893,
RP   AND POLYMORPHISM.
RX   PubMed=9038218; DOI=10.1074/jbc.272.9.5974;
RA   Chen G., Duran G.E., Steger K.A., Lacayo N.J., Jaffrezou J.P.,
RA   Dumontet C., Sikic B.I.;
RT   "Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein,
RT   altered phenotype, and resistance to cyclosporins.";
RL   J. Biol. Chem. 272:5974-5982(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Jiang Y., Sun Q., Xie Z., Liu F., Xu W., Wang Y.;
RT   "Cloning of P-glycoprotein cDNA sequence from breast cancer MCF7 cell
RT   line.";
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-17; ASP-21;
RP   ASN-400; LYS-566; CYS-593; VAL-836; ALA-893; ALA-1051; THR-1141 AND
RP   ILE-1251.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-21.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 178-215 AND 800-856.
RX   PubMed=1972623; DOI=10.1016/0006-291X(90)90401-8;
RA   Gekeler V., Weger S., Probst H.;
RT   "mdr1/P-glycoprotein gene segments analyzed from various human
RT   leukemic cell lines exhibiting different multidrug resistance
RT   profiles.";
RL   Biochem. Biophys. Res. Commun. 169:796-802(1990).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-23 (ISOFORM 1/2).
RX   PubMed=2568832; DOI=10.1016/0006-291X(89)91985-2;
RA   Kioka N., Tsubota J., Kakehi Y., Komano T., Gottesman M.M., Pastan I.,
RA   Ueda K.;
RT   "P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-
RT   glycoprotein carries Gly185 with an altered pattern of multidrug
RT   resistance.";
RL   Biochem. Biophys. Res. Commun. 162:224-231(1989).
RN   [10]
RP   REVIEW.
RX   PubMed=11258197; DOI=10.1517/14622416.2.1.51;
RA   Kerb R., Hoffmeyer S., Brinkmann U.;
RT   "ABC drug transporters: hereditary polymorphisms and pharmacological
RT   impact in MDR1, MRP1 and MRP2.";
RL   Pharmacogenomics 2:51-64(2001).
RN   [11]
RP   INTERACTION WITH PSMB5.
RX   PubMed=15488952; DOI=10.1016/j.molimm.2004.07.005;
RA   Begley G.S., Horvath A.R., Taylor J.C., Higgins C.F.;
RT   "Cytoplasmic domains of the transporter associated with antigen
RT   processing and P-glycoprotein interact with subunits of the
RT   proteasome.";
RL   Mol. Immunol. 42:137-141(2005).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   INTERACTION WITH PPP2R3C.
RX   PubMed=24333728; DOI=10.1016/j.canlet.2013.12.007;
RA   Katayama K., Yamaguchi M., Noguchi K., Sugimoto Y.;
RT   "Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-
RT   glycoprotein/ABCB1 and down-regulates the expression and function.";
RL   Cancer Lett. 345:124-131(2014).
RN   [15]
RP   VARIANT VAL-185, AND POLYMORPHISM.
RX   PubMed=2897240; DOI=10.1016/0092-8674(88)90568-5;
RA   Choi K.H., Chen C.-J., Kriegler M., Roninson I.B.;
RT   "An altered pattern of cross-resistance in multidrug-resistant human
RT   cells results from spontaneous mutations in the mdr1 (P-glycoprotein)
RT   gene.";
RL   Cell 53:519-529(1988).
RN   [16]
RP   VARIANTS ALA-893 AND THR-999.
RX   PubMed=9473242;
RA   Mickley L.A., Lee J.-S., Weng Z., Zhan Z., Alvarez M., Wilson W.,
RA   Bates S.E., Fojo T.;
RT   "Genetic polymorphism in MDR-1: a tool for examining allelic
RT   expression in normal cells, unselected and drug-selected cell lines,
RT   and human tumors.";
RL   Blood 91:1749-1756(1998).
RN   [17]
RP   VARIANT ASP-21.
RX   PubMed=10790226;
RX   DOI=10.1002/(SICI)1098-1004(200005)15:5<486::AID-HUMU26>3.0.CO;2-P;
RA   Decleves X., Chevillard S., Charpentier C., Vielh P., Laplanche J.-L.;
RT   "A new polymorphism (N21D) in the exon 2 of the human MDR1 gene
RT   encoding the P-glycoprotein.";
RL   Hum. Mutat. 15:486-486(2000).
RN   [18]
RP   VARIANTS ASP-21; LEU-103 AND ASN-400.
RX   PubMed=10716719; DOI=10.1073/pnas.97.7.3473;
RA   Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmoeller J.,
RA   Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M.,
RA   Brinkmann U.;
RT   "Functional polymorphisms of the human multidrug-resistance gene:
RT   multiple sequence variations and correlation of one allele with P-
RT   glycoprotein expression and activity in vivo.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:3473-3478(2000).
RN   [19]
RP   VARIANTS ASP-21; ASN-400; ALA-893; THR-893 AND PRO-1107.
RX   PubMed=11240981; DOI=10.1067/mcp.2001.114164;
RA   Cascorbi I., Gerloff T., Johne A., Meisel C., Hoffmeyer S., Schwab M.,
RA   Schaeffeler E., Eichelbaum M., Brinkmann U., Roots I.;
RT   "Frequency of single nucleotide polymorphisms in the P-glycoprotein
RT   drug transporter MDR1 gene in white subjects.";
RL   Clin. Pharmacol. Ther. 69:169-174(2001).
RN   [20]
RP   VARIANT LYS-108.
RX   PubMed=15618700; DOI=10.2133/dmpk.17.479;
RA   Honda T., Dan Y., Koyabu N., Ieiri I., Otsubo K., Higuchi S.,
RA   Ohtani H., Sawada J.;
RT   "Polymorphism of MDR1 gene in healthy Japanese subjects: a novel SNP
RT   with an amino acid substitution (Glu108Lys).";
RL   Drug Metab. Pharmacokinet. 17:479-481(2002).
RN   [21]
RP   VARIANT ILE-1251.
RX   PubMed=15618713; DOI=10.2133/dmpk.17.566;
RA   Itoda M., Saito Y., Komamura K., Ueno K., Kamakura S., Ozawa S.,
RA   Sawada J.;
RT   "Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among
RT   Japanese patients with ventricular tachycardia who were administered
RT   amiodarone.";
RL   Drug Metab. Pharmacokinet. 17:566-571(2002).
RN   [22]
RP   VARIANTS ALA-893 AND THR-893.
RX   PubMed=11829140; DOI=10.1007/s10038-002-8653-6;
RA   Saito S., Iida A., Sekine A., Miura Y., Ogawa C., Kawauchi S.,
RA   Higuchi S., Nakamura Y.;
RT   "Three hundred twenty-six genetic variations in genes encoding nine
RT   members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the
RT   Japanese population.";
RL   J. Hum. Genet. 47:38-50(2002).
RN   [23]
RP   VARIANTS ALA-893 AND THR-893, AND ASSOCIATION WITH SUSCEPTIBILITY TO
RP   IBD13.
RX   PubMed=14610718; DOI=10.1086/379927;
RA   Brant S.R., Panhuysen C.I.M., Nicolae D., Reddy D.M., Bonen D.K.,
RA   Karaliukas R., Zhang L., Swanson E., Datta L.W., Moran T.,
RA   Ravenhill G., Duerr R.H., Achkar J.-P., Karban A.S., Cho J.H.;
RT   "MDR1 Ala893 polymorphism is associated with inflammatory bowel
RT   disease.";
RL   Am. J. Hum. Genet. 73:1282-1292(2003).
RN   [24]
RP   ERRATUM.
RA   Brant S.R., Panhuysen C.I.M., Nicolae D., Reddy D.M., Bonen D.K.,
RA   Karaliukas R., Zhang L., Swanson E., Datta L.W., Moran T.,
RA   Ravenhill G., Duerr R.H., Achkar J.-P., Karban A.S., Cho J.H.;
RL   Am. J. Hum. Genet. 74:1080-1080(2004).
RN   [25]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-887.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Energy-dependent efflux pump responsible for decreased
CC       drug accumulation in multidrug-resistant cells.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + xenobiotic(In) = ADP + phosphate
CC       + xenobiotic(Out).
CC   -!- SUBUNIT: Interacts with PSMB5. Finds in a complex with ABCB1,
CC       TFPI2 and PPP2R3C; leading to the dephosphorylation of ABCB1.
CC       {ECO:0000269|PubMed:15488952, ECO:0000269|PubMed:24333728}.
CC   -!- INTERACTION:
CC       Q86VI4:LAPTM4B; NbExp=2; IntAct=EBI-1057359, EBI-3267258;
CC       Q99496:RNF2; NbExp=2; IntAct=EBI-1057359, EBI-722416;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000255|PROSITE-ProRule:PRU00441}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P08183-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P08183-2; Sequence=VSP_055769;
CC   -!- TISSUE SPECIFICITY: Expressed in liver, kidney, small intestine
CC       and brain.
CC   -!- POLYMORPHISM: Genetic variation in ABCB1 may play a role in
CC       patients who do not respond to drug treatment.
CC       {ECO:0000269|PubMed:2876781, ECO:0000269|PubMed:2897240,
CC       ECO:0000269|PubMed:9038218}.
CC   -!- DISEASE: Inflammatory bowel disease 13 (IBD13) [MIM:612244]: A
CC       chronic, relapsing inflammation of the gastrointestinal tract with
CC       a complex etiology. It is subdivided into Crohn disease and
CC       ulcerative colitis phenotypes. Crohn disease may affect any part
CC       of the gastrointestinal tract from the mouth to the anus, but most
CC       frequently it involves the terminal ileum and colon. Bowel
CC       inflammation is transmural and discontinuous; it may contain
CC       granulomas or be associated with intestinal or perianal fistulas.
CC       In contrast, in ulcerative colitis, the inflammation is continuous
CC       and limited to rectal and colonic mucosal layers; fistulas and
CC       granulomas are not observed. Both diseases include extraintestinal
CC       inflammation of the skin, eyes, or joints. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCB
CC       family. Multidrug resistance exporter (TC 3.A.1.201) subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAM49149.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PGY1ID105.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/abcb1/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=ABCB1";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P-glycoprotein entry;
CC       URL="https://en.wikipedia.org/wiki/P-glycoprotein";
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC
CC       proteins;
CC       URL="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=P08183";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14758; AAA59575.1; -; mRNA.
DR   EMBL; M29447; AAA59576.1; -; Genomic_DNA.
DR   EMBL; M29424; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29425; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29426; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29427; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29428; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29429; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29430; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29431; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29432; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29433; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29434; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29435; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29436; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29437; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29438; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29439; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29440; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29441; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29442; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29443; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29444; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29445; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; M29446; AAA59576.1; JOINED; Genomic_DNA.
DR   EMBL; AF016535; AAB69423.1; -; mRNA.
DR   EMBL; EU854148; ACF94688.1; -; mRNA.
DR   EMBL; AY910577; AAW82430.1; -; Genomic_DNA.
DR   EMBL; AK290159; BAF82848.1; -; mRNA.
DR   EMBL; AC002457; AAM49149.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC005068; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M37724; AAA88047.1; -; Genomic_DNA.
DR   EMBL; M37725; AAA88048.1; -; Genomic_DNA.
DR   EMBL; X58723; CAA41558.1; -; Genomic_DNA.
DR   CCDS; CCDS5608.1; -. [P08183-1]
DR   PIR; A34914; DVHU1.
DR   RefSeq; NP_000918.2; NM_000927.4. [P08183-1]
DR   UniGene; Hs.489033; -.
DR   UniGene; Hs.689936; -.
DR   UniGene; Hs.737655; -.
DR   ProteinModelPortal; P08183; -.
DR   SMR; P08183; -.
DR   BioGrid; 111262; 14.
DR   IntAct; P08183; 6.
DR   MINT; MINT-5000901; -.
DR   STRING; 9606.ENSP00000265724; -.
DR   BindingDB; P08183; -.
DR   ChEMBL; CHEMBL4302; -.
DR   DrugBank; DB01193; Acebutolol.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB08916; Afatinib.
DR   DrugBank; DB00518; Albendazole.
DR   DrugBank; DB04630; Aldosterone.
DR   DrugBank; DB11363; Alectinib.
DR   DrugBank; DB00802; Alfentanil.
DR   DrugBank; DB00523; Alitretinoin.
DR   DrugBank; DB00915; Amantadine.
DR   DrugBank; DB06403; Ambrisentan.
DR   DrugBank; DB00345; Aminohippuric acid.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB00701; Amprenavir.
DR   DrugBank; DB00276; Amsacrine.
DR   DrugBank; DB06605; Apixaban.
DR   DrugBank; DB01169; Arsenic trioxide.
DR   DrugBank; DB00637; Astemizole.
DR   DrugBank; DB01072; Atazanavir.
DR   DrugBank; DB00335; Atenolol.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB06626; Axitinib.
DR   DrugBank; DB00972; Azelastine.
DR   DrugBank; DB00207; Azithromycin.
DR   DrugBank; DB01086; Benzocaine.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB00443; Betamethasone.
DR   DrugBank; DB00810; Biperiden.
DR   DrugBank; DB08873; Boceprevir.
DR   DrugBank; DB06616; Bosutinib.
DR   DrugBank; DB08870; Brentuximab vedotin.
DR   DrugBank; DB01200; Bromocriptine.
DR   DrugBank; DB00921; Buprenorphine.
DR   DrugBank; DB00490; Buspirone.
DR   DrugBank; DB06772; Cabazitaxel.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB04690; Camptothecin.
DR   DrugBank; DB08907; Canagliflozin.
DR   DrugBank; DB00796; Candesartan.
DR   DrugBank; DB01197; Captopril.
DR   DrugBank; DB00564; Carbamazepine.
DR   DrugBank; DB08889; Carfilzomib.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00520; Caspofungin.
DR   DrugBank; DB09063; Ceritinib.
DR   DrugBank; DB00439; Cerivastatin.
DR   DrugBank; DB00608; Chloroquine.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB00672; Chlorpropamide.
DR   DrugBank; DB01239; Chlorprothixene.
DR   DrugBank; DB04540; Cholesterol.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB01340; Cilazapril.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB00537; Ciprofloxacin.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB00215; Citalopram.
DR   DrugBank; DB01211; Clarithromycin.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB00845; Clofazimine.
DR   DrugBank; DB00882; Clomifene.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB00575; Clonidine.
DR   DrugBank; DB00758; Clopidogrel.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB09065; Cobicistat.
DR   DrugBank; DB05239; Cobimetinib.
DR   DrugBank; DB01394; Colchicine.
DR   DrugBank; DB02587; Colforsin.
DR   DrugBank; DB00286; Conjugated Equine Estrogens.
DR   DrugBank; DB08865; Crizotinib.
DR   DrugBank; DB00531; Cyclophosphamide.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB06695; Dabigatran etexilate.
DR   DrugBank; DB08912; Dabrafenib.
DR   DrugBank; DB09102; Daclatasvir.
DR   DrugBank; DB00970; Dactinomycin.
DR   DrugBank; DB06292; Dapagliflozin.
DR   DrugBank; DB01254; Dasatinib.
DR   DrugBank; DB00694; Daunorubicin.
DR   DrugBank; DB04840; Debrisoquin.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB00967; Desloratadine.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00255; Diethylstilbestrol.
DR   DrugBank; DB01396; Digitoxin.
DR   DrugBank; DB00390; Digoxin.
DR   DrugBank; DB00320; Dihydroergotamine.
DR   DrugBank; DB02901; Dihydrotestosterone.
DR   DrugBank; DB00343; Diltiazem.
DR   DrugBank; DB00975; Dipyridamole.
DR   DrugBank; DB01248; Docetaxel.
DR   DrugBank; DB01184; Domperidone.
DR   DrugBank; DB00590; Doxazosin.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB00470; Dronabinol.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB09075; Edoxaban.
DR   DrugBank; DB04881; Elacridar.
DR   DrugBank; DB11574; Elbasvir.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB00584; Enalapril.
DR   DrugBank; DB08899; Enzalutamide.
DR   DrugBank; DB00751; Epinastine.
DR   DrugBank; DB01253; Ergonovine.
DR   DrugBank; DB00696; Ergotamine.
DR   DrugBank; DB00530; Erlotinib.
DR   DrugBank; DB00199; Erythromycin.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB01196; Estramustine.
DR   DrugBank; DB04573; Estriol.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB00977; Ethinyl Estradiol.
DR   DrugBank; DB00773; Etoposide.
DR   DrugBank; DB06414; Etravirine.
DR   DrugBank; DB00973; Ezetimibe.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB00813; Fentanyl.
DR   DrugBank; DB06702; Fesoterodine.
DR   DrugBank; DB00950; Fexofenadine.
DR   DrugBank; DB08874; Fidaxomicin.
DR   DrugBank; DB00196; Fluconazole.
DR   DrugBank; DB00472; Fluoxetine.
DR   DrugBank; DB00875; Flupentixol.
DR   DrugBank; DB00623; Fluphenazine.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB08906; Fluticasone furoate.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB05449; FM-VP4.
DR   DrugBank; DB00317; Gefitinib.
DR   DrugBank; DB00441; Gemcitabine.
DR   DrugBank; DB01645; Genistein.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB04077; Glycerol.
DR   DrugBank; DB00027; Gramicidin D.
DR   DrugBank; DB11575; Grazoprevir.
DR   DrugBank; DB00365; Grepafloxacin.
DR   DrugBank; DB00502; Haloperidol.
DR   DrugBank; DB00741; Hydrocortisone.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB09054; Idelalisib.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB05039; Indacaterol.
DR   DrugBank; DB00224; Indinavir.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB06636; Isavuconazonium.
DR   DrugBank; DB01167; Itraconazole.
DR   DrugBank; DB08820; Ivacaftor.
DR   DrugBank; DB00602; Ivermectin.
DR   DrugBank; DB01221; Ketamine.
DR   DrugBank; DB01587; Ketazolam.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB00709; Lamivudine.
DR   DrugBank; DB00555; Lamotrigine.
DR   DrugBank; DB00448; Lansoprazole.
DR   DrugBank; DB01259; Lapatinib.
DR   DrugBank; DB00480; Lenalidomide.
DR   DrugBank; DB09078; Lenvatinib.
DR   DrugBank; DB01202; Levetiracetam.
DR   DrugBank; DB01137; Levofloxacin.
DR   DrugBank; DB08918; Levomilnacipran.
DR   DrugBank; DB00451; Levothyroxine.
DR   DrugBank; DB00281; Lidocaine.
DR   DrugBank; DB08882; Linagliptin.
DR   DrugBank; DB00279; Liothyronine.
DR   DrugBank; DB01583; Liotrix.
DR   DrugBank; DB00722; Lisinopril.
DR   DrugBank; DB08827; Lomitapide.
DR   DrugBank; DB00836; Loperamide.
DR   DrugBank; DB01601; Lopinavir.
DR   DrugBank; DB00455; Loratadine.
DR   DrugBank; DB00678; Losartan.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB00742; Mannitol.
DR   DrugBank; DB00934; Maprotiline.
DR   DrugBank; DB00643; Mebendazole.
DR   DrugBank; DB00358; Mefloquine.
DR   DrugBank; DB00351; Megestrol acetate.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00959; Methylprednisolone.
DR   DrugBank; DB00264; Metoprolol.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB00834; Mifepristone.
DR   DrugBank; DB08893; Mirabegron.
DR   DrugBank; DB00305; Mitomycin.
DR   DrugBank; DB01204; Mitoxantrone.
DR   DrugBank; DB00295; Morphine.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB01203; Nadolol.
DR   DrugBank; DB01183; Naloxone.
DR   DrugBank; DB00704; Naltrexone.
DR   DrugBank; DB03467; Naringenin.
DR   DrugBank; DB01149; Nefazodone.
DR   DrugBank; DB00220; Nelfinavir.
DR   DrugBank; DB01400; Neostigmine.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB04868; Nilotinib.
DR   DrugBank; DB09079; Nintedanib.
DR   DrugBank; DB00401; Nisoldipine.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB01054; Nitrendipine.
DR   DrugBank; DB00585; Nizatidine.
DR   DrugBank; DB00717; Norethisterone.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB09296; Ombitasvir.
DR   DrugBank; DB00338; Omeprazole.
DR   DrugBank; DB09330; Osimertinib.
DR   DrugBank; DB04417; P-Nitrophenol.
DR   DrugBank; DB01229; Paclitaxel.
DR   DrugBank; DB03796; Palmitic Acid.
DR   DrugBank; DB06603; Panobinostat.
DR   DrugBank; DB00213; Pantoprazole.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB06589; Pazopanib.
DR   DrugBank; DB00790; Perindopril.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugBank; DB01100; Pimozide.
DR   DrugBank; DB08860; Pitavastatin.
DR   DrugBank; DB02261; Platelet Activating Factor.
DR   DrugBank; DB08910; Pomalidomide.
DR   DrugBank; DB08901; Ponatinib.
DR   DrugBank; DB01263; Posaconazole.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB00457; Prazosin.
DR   DrugBank; DB00860; Prednisolone.
DR   DrugBank; DB00635; Prednisone.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB01069; Promethazine.
DR   DrugBank; DB01182; Propafenone.
DR   DrugBank; DB00571; Propranolol.
DR   DrugBank; DB00344; Protriptyline.
DR   DrugBank; DB04216; Quercetin.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB01103; Quinacrine.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB00863; Ranitidine.
DR   DrugBank; DB00234; Reboxetine.
DR   DrugBank; DB08896; Regorafenib.
DR   DrugBank; DB00206; Reserpine.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB08864; Rilpivirine.
DR   DrugBank; DB00734; Risperidone.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB06228; Rivaroxaban.
DR   DrugBank; DB09291; Rolapitant.
DR   DrugBank; DB06176; Romidepsin.
DR   DrugBank; DB00778; Roxithromycin.
DR   DrugBank; DB00936; Salicylic acid.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB00747; Scopolamine.
DR   DrugBank; DB01037; Selegiline.
DR   DrugBank; DB11362; Selexipag.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB06207; Silodosin.
DR   DrugBank; DB06290; Simeprevir.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB00877; Sirolimus.
DR   DrugBank; DB01261; Sitagliptin.
DR   DrugBank; DB08934; Sofosbuvir.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB01208; Sparfloxacin.
DR   DrugBank; DB03203; Sphingosine.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB01323; St. John's Wort.
DR   DrugBank; DB02010; Staurosporine.
DR   DrugBank; DB00428; Streptozocin.
DR   DrugBank; DB01138; Sulfinpyrazone.
DR   DrugBank; DB00669; Sumatriptan.
DR   DrugBank; DB01268; Sunitinib.
DR   DrugBank; DB00382; Tacrine.
DR   DrugBank; DB00864; Tacrolimus.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB04348; Taurocholic Acid.
DR   DrugBank; DB09161; Technetium Tc-99m sestamibi.
DR   DrugBank; DB05521; Telaprevir.
DR   DrugBank; DB00966; Telmisartan.
DR   DrugBank; DB06287; Temsirolimus.
DR   DrugBank; DB01162; Terazosin.
DR   DrugBank; DB00342; Terfenadine.
DR   DrugBank; DB04905; Tesmilifene.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB08816; Ticagrelor.
DR   DrugBank; DB00373; Timolol.
DR   DrugBank; DB06212; Tolvaptan.
DR   DrugBank; DB01030; Topotecan.
DR   DrugBank; DB00539; Toremifene.
DR   DrugBank; DB05773; Trastuzumab emtansine.
DR   DrugBank; DB00656; Trazodone.
DR   DrugBank; DB00831; Trifluoperazine.
DR   DrugBank; DB00508; Triflupromazine.
DR   DrugBank; DB00440; Trimethoprim.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB01361; Troleandomycin.
DR   DrugBank; DB08867; Ulipristal.
DR   DrugBank; DB09076; Umeclidinium.
DR   DrugBank; DB01339; Vecuronium.
DR   DrugBank; DB11581; Venetoclax.
DR   DrugBank; DB00285; Venlafaxine.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB00570; Vinblastine.
DR   DrugBank; DB00541; Vincristine.
DR   DrugBank; DB00361; Vinorelbine.
DR   DrugBank; DB08828; Vismodegib.
DR   DrugBank; DB04877; Voacamine.
DR   DrugBank; DB00495; Zidovudine.
DR   DrugBank; DB04832; Zimelidine.
DR   SwissLipids; SLP:000000385; -.
DR   MoonProt; P08183; -.
DR   TCDB; 3.A.1.201.1; the atp-binding cassette (abc) superfamily.
DR   iPTMnet; P08183; -.
DR   PhosphoSitePlus; P08183; -.
DR   BioMuta; ABCB1; -.
DR   DMDM; 238054374; -.
DR   EPD; P08183; -.
DR   MaxQB; P08183; -.
DR   PaxDb; P08183; -.
DR   PeptideAtlas; P08183; -.
DR   PRIDE; P08183; -.
DR   DNASU; 5243; -.
DR   Ensembl; ENST00000265724; ENSP00000265724; ENSG00000085563. [P08183-1]
DR   Ensembl; ENST00000543898; ENSP00000444095; ENSG00000085563. [P08183-2]
DR   Ensembl; ENST00000622132; ENSP00000478255; ENSG00000085563. [P08183-1]
DR   GeneID; 5243; -.
DR   KEGG; hsa:5243; -.
DR   UCSC; uc003uiz.3; human. [P08183-1]
DR   CTD; 5243; -.
DR   DisGeNET; 5243; -.
DR   GeneCards; ABCB1; -.
DR   H-InvDB; HIX0033521; -.
DR   HGNC; HGNC:40; ABCB1.
DR   HPA; CAB001716; -.
DR   HPA; HPA002199; -.
DR   MalaCards; ABCB1; -.
DR   MIM; 171050; gene.
DR   MIM; 612244; phenotype.
DR   neXtProt; NX_P08183; -.
DR   OpenTargets; ENSG00000085563; -.
DR   Orphanet; 771; Ulcerative colitis.
DR   PharmGKB; PA267; -.
DR   eggNOG; KOG0055; Eukaryota.
DR   eggNOG; COG1132; LUCA.
DR   GeneTree; ENSGT00530000062896; -.
DR   HOVERGEN; HBG080809; -.
DR   InParanoid; P08183; -.
DR   KO; K05658; -.
DR   OMA; SQGQDRK; -.
DR   OrthoDB; EOG091G0HVA; -.
DR   PhylomeDB; P08183; -.
DR   TreeFam; TF105193; -.
DR   BRENDA; 3.6.3.44; 2681.
DR   Reactome; R-HSA-2161517; Abacavir transmembrane transport.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   ChiTaRS; ABCB1; human.
DR   GeneWiki; P-glycoprotein; -.
DR   GenomeRNAi; 5243; -.
DR   PRO; PR:P08183; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000085563; -.
DR   CleanEx; HS_ABCB1; -.
DR   ExpressionAtlas; P08183; baseline and differential.
DR   Genevisible; P08183; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:DFLAT.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; TAS:ProtInc.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc.
DR   GO; GO:0099038; F:ceramide-translocating ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0090554; F:phosphatidylcholine-translocating ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0090555; F:phosphatidylethanolamine-translocating ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0008559; F:xenobiotic-transporting ATPase activity; TAS:Reactome.
DR   GO; GO:0099040; P:ceramide translocation; IDA:BHF-UCL.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:DFLAT.
DR   GO; GO:0045332; P:phospholipid translocation; IDA:BHF-UCL.
DR   GO; GO:1901529; P:positive regulation of anion channel activity; IMP:CAFA.
DR   GO; GO:2001225; P:regulation of chloride transport; IMP:CAFA.
DR   GO; GO:0047484; P:regulation of response to osmotic stress; IMP:CAFA.
DR   GO; GO:0042493; P:response to drug; TAS:ProtInc.
DR   GO; GO:0072089; P:stem cell proliferation; IMP:DFLAT.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF90123; SSF90123; 2.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 2.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Glycoprotein; Hydrolase; Membrane; Nucleotide-binding; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   1280       Multidrug resistance protein 1.
FT                                /FTId=PRO_0000093332.
FT   TOPO_DOM      1     44       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     45     67       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM     68    116       Extracellular. {ECO:0000250}.
FT   TRANSMEM    117    137       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    138    186       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    187    208       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    209    215       Extracellular. {ECO:0000250}.
FT   TRANSMEM    216    236       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    237    292       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    293    316       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    317    330       Extracellular. {ECO:0000250}.
FT   TRANSMEM    331    352       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    353    711       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    712    732       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    733    756       Extracellular. {ECO:0000250}.
FT   TRANSMEM    757    777       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    778    832       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    833    853       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    854    854       Extracellular. {ECO:0000250}.
FT   TRANSMEM    855    874       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    875    934       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    935    957       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    958    973       Extracellular. {ECO:0000250}.
FT   TRANSMEM    974    995       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    996   1280       Cytoplasmic. {ECO:0000250}.
FT   DOMAIN       51    357       ABC transmembrane type-1 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN      392    628       ABC transporter 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   DOMAIN      711   1000       ABC transmembrane type-1 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN     1035   1273       ABC transporter 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     427    434       ATP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND    1070   1077       ATP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   CARBOHYD     91     91       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     94     94       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     99     99       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     113    177       RYAYYYSGIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFH
FT                                AIMRQEIGWFDVHDVGELNTRLTD -> S (in isoform
FT                                2). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_055769.
FT   VARIANT      17     17       F -> L (in dbSNP:rs28381804).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_022276.
FT   VARIANT      21     21       N -> D (in dbSNP:rs9282564).
FT                                {ECO:0000269|PubMed:10716719,
FT                                ECO:0000269|PubMed:10790226,
FT                                ECO:0000269|PubMed:11240981,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_014704.
FT   VARIANT      44     44       N -> S (in dbSNP:rs1202183).
FT                                /FTId=VAR_055423.
FT   VARIANT      80     80       A -> E (in dbSNP:rs9282565).
FT                                /FTId=VAR_055424.
FT   VARIANT     103    103       F -> L (rare polymorphism).
FT                                {ECO:0000269|PubMed:10716719}.
FT                                /FTId=VAR_015001.
FT   VARIANT     108    108       E -> K. {ECO:0000269|PubMed:15618700}.
FT                                /FTId=VAR_018351.
FT   VARIANT     185    185       G -> V (in a colchicine-selected
FT                                multidrug-resistant cell line; confers
FT                                increased resistance to colchicine;
FT                                dbSNP:rs1128501).
FT                                {ECO:0000269|PubMed:2876781,
FT                                ECO:0000269|PubMed:2897240,
FT                                ECO:0000269|PubMed:9038218}.
FT                                /FTId=VAR_015002.
FT   VARIANT     261    261       I -> V (in dbSNP:rs36008564).
FT                                /FTId=VAR_055425.
FT   VARIANT     400    400       S -> N (in dbSNP:rs2229109).
FT                                {ECO:0000269|PubMed:10716719,
FT                                ECO:0000269|PubMed:11240981,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_015003.
FT   VARIANT     566    566       E -> K (in dbSNP:rs28381902).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_022277.
FT   VARIANT     593    593       R -> C (in dbSNP:rs28381914).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_022278.
FT   VARIANT     599    599       A -> T (in dbSNP:rs2235036).
FT                                /FTId=VAR_055426.
FT   VARIANT     669    669       R -> C (in dbSNP:rs35023033).
FT                                /FTId=VAR_055427.
FT   VARIANT     801    801       V -> M (in dbSNP:rs2235039).
FT                                /FTId=VAR_055428.
FT   VARIANT     829    829       I -> V (in dbSNP:rs2032581).
FT                                /FTId=VAR_055429.
FT   VARIANT     836    836       I -> V (in dbSNP:rs28381967).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_022279.
FT   VARIANT     887    887       K -> N (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035737.
FT   VARIANT     893    893       S -> A (common allele; associated with
FT                                susceptibility to IBD13; has decreased
FT                                enzyme activity; dbSNP:rs2032582).
FT                                {ECO:0000269|PubMed:11240981,
FT                                ECO:0000269|PubMed:11829140,
FT                                ECO:0000269|PubMed:14610718,
FT                                ECO:0000269|PubMed:1967175,
FT                                ECO:0000269|PubMed:2876781,
FT                                ECO:0000269|PubMed:9038218,
FT                                ECO:0000269|PubMed:9473242,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_013361.
FT   VARIANT     893    893       S -> T (rare allele; dbSNP:rs2032582).
FT                                {ECO:0000269|PubMed:11240981,
FT                                ECO:0000269|PubMed:11829140,
FT                                ECO:0000269|PubMed:14610718}.
FT                                /FTId=VAR_013362.
FT   VARIANT     986    986       M -> V.
FT                                /FTId=VAR_018352.
FT   VARIANT     999    999       A -> T (in dbSNP:rs72552784).
FT                                {ECO:0000269|PubMed:9473242}.
FT                                /FTId=VAR_015004.
FT   VARIANT    1051   1051       P -> A (in dbSNP:rs28401798).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_022280.
FT   VARIANT    1107   1107       Q -> P (in dbSNP:rs55852620).
FT                                {ECO:0000269|PubMed:11240981}.
FT                                /FTId=VAR_015005.
FT   VARIANT    1141   1141       S -> T (in dbSNP:rs2229107).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_022281.
FT   VARIANT    1251   1251       V -> I (in dbSNP:rs28364274).
FT                                {ECO:0000269|PubMed:15618713,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018353.
FT   CONFLICT     23     23       S -> R (in Ref. 9; CAA41558).
FT                                {ECO:0000305}.
FT   CONFLICT    336    336       Missing (in Ref. 3; AAB69423).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1280 AA;  141479 MW;  F0230744AB288C73 CRC64;
     MDLEGDRNGG AKKKNFFKLN NKSEKDKKEK KPTVSVFSMF RYSNWLDKLY MVVGTLAAII
     HGAGLPLMML VFGEMTDIFA NAGNLEDLMS NITNRSDIND TGFFMNLEED MTRYAYYYSG
     IGAGVLVAAY IQVSFWCLAA GRQIHKIRKQ FFHAIMRQEI GWFDVHDVGE LNTRLTDDVS
     KINEGIGDKI GMFFQSMATF FTGFIVGFTR GWKLTLVILA ISPVLGLSAA VWAKILSSFT
     DKELLAYAKA GAVAEEVLAA IRTVIAFGGQ KKELERYNKN LEEAKRIGIK KAITANISIG
     AAFLLIYASY ALAFWYGTTL VLSGEYSIGQ VLTVFFSVLI GAFSVGQASP SIEAFANARG
     AAYEIFKIID NKPSIDSYSK SGHKPDNIKG NLEFRNVHFS YPSRKEVKIL KGLNLKVQSG
     QTVALVGNSG CGKSTTVQLM QRLYDPTEGM VSVDGQDIRT INVRFLREII GVVSQEPVLF
     ATTIAENIRY GRENVTMDEI EKAVKEANAY DFIMKLPHKF DTLVGERGAQ LSGGQKQRIA
     IARALVRNPK ILLLDEATSA LDTESEAVVQ VALDKARKGR TTIVIAHRLS TVRNADVIAG
     FDDGVIVEKG NHDELMKEKG IYFKLVTMQT AGNEVELENA ADESKSEIDA LEMSSNDSRS
     SLIRKRSTRR SVRGSQAQDR KLSTKEALDE SIPPVSFWRI MKLNLTEWPY FVVGVFCAII
     NGGLQPAFAI IFSKIIGVFT RIDDPETKRQ NSNLFSLLFL ALGIISFITF FLQGFTFGKA
     GEILTKRLRY MVFRSMLRQD VSWFDDPKNT TGALTTRLAN DAAQVKGAIG SRLAVITQNI
     ANLGTGIIIS FIYGWQLTLL LLAIVPIIAI AGVVEMKMLS GQALKDKKEL EGSGKIATEA
     IENFRTVVSL TQEQKFEHMY AQSLQVPYRN SLRKAHIFGI TFSFTQAMMY FSYAGCFRFG
     AYLVAHKLMS FEDVLLVFSA VVFGAMAVGQ VSSFAPDYAK AKISAAHIIM IIEKTPLIDS
     YSTEGLMPNT LEGNVTFGEV VFNYPTRPDI PVLQGLSLEV KKGQTLALVG SSGCGKSTVV
     QLLERFYDPL AGKVLLDGKE IKRLNVQWLR AHLGIVSQEP ILFDCSIAEN IAYGDNSRVV
     SQEEIVRAAK EANIHAFIES LPNKYSTKVG DKGTQLSGGQ KQRIAIARAL VRQPHILLLD
     EATSALDTES EKVVQEALDK AREGRTCIVI AHRLSTIQNA DLIVVFQNGR VKEHGTHQQL
     LAQKGIYFSM VSVQAGTKRQ
//
